BioXcel Therapeutics, Inc. (BTAI) Reports Material Event to SEC
Filing Details BioXcel Therapeutics, Inc. (NASDAQ:BTAI) filed a Form 8-K with the Securities and Exchange Commission on July 06, 2026, disclosing a material event. Market Context…
Read more
